On Friday 30th October Macuject will be featured at Australia’s largest life science conference - AusBiotech + Invest 2020.
As one of just 15 companies presenting at the Early Stage Investment Forum, Macuject will be pitching to a wide audience of potential investors and partners. Followed by a live Q&A session, the opportunity to share our developments and future plans is exciting.
The 3-day conference, which is celebrating its 35th year, will take place in a virtual format combined with live sessions, a business matching programme and access to global investors and industry experts.
Dr Chauhan’s presentation will address the global problem of undertreatment with intravitreal injections for wet macular degeneration. His presentation will describe how Macuject can assist by increasing the capacity of doctors who currently perform anti-VEGF injections and enable non-retinal specialists to deliver these treatments with increased clinical confidence.
He will also highlight the unprecedented data insights Macuject can generate for doctors and Pharma alike.
The Macuject team will be connecting with new commercial partners and investors keen to join us in our next phase of development and regulatory work, heading towards market launch.
Join us there: